<p>Emtricitabine is indicated in combination with other medications for the treatment of HIV-1 infections;<sup class="text-reference-group"><a class="reference-popover-link" data-content="FDA Approved Drug Products: Emtriva (Emtricitabine) Oral Capsules" href="#reference-L9019">6</a>,<a class="reference-popover-link" data-content="FDA Approved Drug Products: Symtuza (Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) Oral Tablets" href="#reference-L9836">10</a></sup> treatment of HIV-1 infections in pediatric patients 25-35kg, treatment of HIV-1 infections in adult patients ≥35kg, for pre exposure prophylaxis of HIV-1 in adolescent and adult patients excluding those who have receptive vaginal sex;<sup class="text-reference-group"><a class="reference-popover-link" data-content="FDA Approved Drug Products: Descovy (Emtricitabine and Tenofovir Alafenamide) Oral Tablets" href="#reference-L4388">7</a>,<a class="reference-popover-link" data-content="FDA Press Announcements: FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic" href="#reference-L9010">5</a></sup> treatment of HIV-1 infections in pediatric and adult patients ≥17kg, pre exposure prophylaxis in adolescents and adults ≥35kg;<sup class="text-reference-group"><a class="reference-popover-link" data-content="FDA Approved Drug Products: Truvada (emtricitabine and tenofovir disoproxil fumarate) tablets for oral use" href="#reference-L9833">9</a></sup> treatment of HIV-1 in patients ≥12 years and ≥35kg;<sup class="text-reference-group"><a class="reference-popover-link" data-content="FDA Approved Drug Products: Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets for oral use" href="#reference-L9587">11</a></sup> treatment of HIV-1 in patients weighing ≥35kg;<sup class="text-reference-group"><a class="reference-popover-link" data-content="FDA Approved Drug Products: Odefsey (Emtricitabine, Rilpivirine, and Tenofovir Alafenamide)" href="#reference-L9839">12</a>,<a class="reference-popover-link" data-content="FDA Approved Drug Products: Complera (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets for oral use" href="#reference-L9842">14</a></sup> treatment of HIV-1 in patients weighing ≥25kg;<sup class="text-reference-group"><a class="reference-popover-link" data-content="FDA Approved Drug Products: Genvoya (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) Oral Tablets" href="#reference-L9647">13</a>,<a class="reference-popover-link" data-content="FDA Approved Drug Products: Biktarvy (Bictegravir, Emtricitabine, and Tenofovir Alafenamide) Oral Tablets" href="#reference-L9845">15</a></sup> and treatment of HIV-1 in patients weighing ≥40kg.<sup class="text-reference-group"><a class="reference-popover-link" data-content="FDA Approved Drug Products: Atripla (efavirenz, emtricitabine, and tenofovir disoproxil fumarate) tablets for oral use" href="#reference-L9848">16</a></sup></p>